NCT03731650

Brief Summary

twenty recruited patients indicated for sinus augmentation and simultaneous implant placement will be divided into two groups (10 in each of the groups).to evaluate \& compare bone formation \& implant stability after shneiderian membrane elevation and augmentation with graft less tenting technique with different implant lengths. group one will receive 8mm implant lenght while group two will receive 10mm implants.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 6, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2019

Completed
Last Updated

November 6, 2018

Status Verified

November 1, 2018

Enrollment Period

7 months

First QC Date

September 12, 2018

Last Update Submit

November 3, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • height of gained bone

    two cone beam CT will be done for the patients, one immediate post operative \& the other 6 months post operative then the amount of gained bone will be assessed by superimposing the same section in the two cone beam CT.

    6 months post operative

Secondary Outcomes (1)

  • implant stability

    will be measured intra operative after implant insertion and will be measured once more 6 months post operative after the first operation at the time of implant exposure

Study Arms (2)

active comparator

EXPERIMENTAL
Procedure: maxillary sinus lift

placebo

EXPERIMENTAL
Procedure: maxillary sinus lift

Interventions

non grafted maxillary sinus floor augmentation with simultaneous implant placement

active comparatorplacebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient with atrophic maxilla \& pneumatized maxillary sinus with residual bone height at least 4mm of residual ridge
  • both sexes

You may not qualify if:

  • patients with systematic diseases that may affect normal healing
  • sinus pathology
  • heavy smokers more than 20 cigarettes per day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

ahmed abdul nasser ali, BDS

CONTACT

ahmed abdel rahman mohammed, MDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

September 12, 2018

First Posted

November 6, 2018

Study Start

January 1, 2019

Primary Completion

August 1, 2019

Study Completion

August 15, 2019

Last Updated

November 6, 2018

Record last verified: 2018-11